M&G Investment Management LTD Arcus Biosciences, Inc. Transaction History

M&G Investment Management LTD

  • $28.2 Trillion
  • Q4 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 18, 2022
SELL
$31.38 - $48.47 $1.31 Million - $2.02 Million
-41,631 Closed
0 $0
Q3 2021

Nov 09, 2021
BUY
$26.93 - $37.68 $1.12 Million - $1.57 Million
41,631 New
41,631 $1.45 Million
Q3 2020

Oct 26, 2020
SELL
$17.14 - $25.47 $265,155 - $394,020
-15,470 Closed
0 $0
Q2 2020

Jul 22, 2020
BUY
$13.97 - $36.56 $216,115 - $565,583
15,470 New
15,470 $387,000

Others Institutions Holding RCUS

# of Institutions
200
Shares Held
51.5M
Call Options Held
236K
Put Options Held
141K
View Full List

About Arcus Biosciences, Inc.

RCUS Quotes by TradingView
  • Ticker RCUS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,160,000
  • Market Cap $950M
  • Description
  • Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...
More about RCUS
Track This Portfolio

Track M&G Investment Management LTD Portfolio

Follow M&G Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on M&G Investment Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email